PHASE-I DOSE-ESCALATION TRIAL OF I-131-LABELED MN-14 F(AB)(2) ANTI-CEA MAB IN PATIENTS WITH MEDULLARY-THYROID CANCER (MTC)

Authors
JUWEID M SHARKEY RM SWAYNE LC PETRYK L DUNN R RUBIN A HERSKOVIC T GOLDENBERG DM
Citation
M. Juweid et al., PHASE-I DOSE-ESCALATION TRIAL OF I-131-LABELED MN-14 F(AB)(2) ANTI-CEA MAB IN PATIENTS WITH MEDULLARY-THYROID CANCER (MTC), The Journal of nuclear medicine, 38(5), 1997, pp. 1115-1115
Citations number
NO
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
Journal title
The Journal of nuclear medicine → ACNP
ISSN journal
01615505
Volume
38
Issue
5
Year of publication
1997
Supplement
S
Pages
1115 - 1115
Database
ISI
SICI code
0161-5505(1997)38:5<1115:PDTOIM>2.0.ZU;2-T